[ad_1]
This is announced by the Public Health Agency.
“The Swedish Public Health Agency has decided to recommend that regions of the country continue to pause the use of the Astra Zeneca vaccine among people under 65 years of age, until further notice and pending further data on the safety of those ages However, the work of vaccinating people over 65 can be resumed, “the authority wrote in a press release.
“I need a few more weeks”
– There are a number of signs among the youngest. So we think it’s reasonable to give it a few more weeks, says Anders Tegnell of the breakdown around the Astra Zeneca vaccine among people under 65, at today’s press conference.
– Then we will see in a few weeks if there is reason to vaccinate larger groups, says Tegnell and emphasizes that right now it is important to prioritize older people.
The investigation continues
The Medical Products Agency writes in a press release: “Investigation of the rare suspected side effects that have been reported continues, and the benefit of the vaccine is still considered significantly greater than the risk of side effects.”
The announcement comes after Astra Zeneca’s covid vaccine vaccines were stopped last week. The Public Health Agency decided to arrest after alarms about suspected side effects: a combination of blood clots and a lack of platelets.
Investigation of a possible causal link to the vaccine is still ongoing at the EU level, and suspected side effects are not something that was previously included in the product information until recently, when the Agency for Medical Products updated the leaflet.
“A combination of thrombosis and thrombocytopenia has been observed, in some cases along with bleeding, in very rare cases after vaccination,” writes the Medical Products Agency in the Astra vaccine product information.
Still under investigation
However, this still does not mean that the combination of blood clots and a lack of platelets counts as an established side effect.
– It is included as a warning and the investigation is still ongoing. A causal relationship has not yet been established, says Charlotta Bergquist, vaccine coordinator for the Medical Products Agency.
So far, there have been two confirmed cases in Sweden and as many as 30 in the world. In the product information, the Medical Products Agency writes that “most of these cases occurred within the first 7 to 14 days after vaccination and occurred in most cases in women under 55 years of age, but this may reflect the increased use of the vaccine in this population. Some cases were fatal. “
Be an observer
The Medical Products Agency also urges healthcare professionals to be vigilant and report suspicious combinations of blood clots and low platelet levels after vaccination.
– I want to take the opportunity to say that it is important. If you have patients with suspected blood clots and low platelet levels, you really should report it, even if it is a very stressful situation for staff, unit manager Veronica Arthurson told TT on Wednesday.
Erik Nilsson / TT
